Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Cost-Effectiveness Analysis of Nirsevimab and Maternal Rsvpref Vaccine Strategies for Prevention of Respiratory Syncytial Virus Disease Among Infants in Canada: A Simulation Study
2023
· Yale University,
· York University,
· Dalhousie University
This study in Canada assessed cost-effectiveness of nirsevimab and RSVpreF for preventing RSV in infants. Modeling different interventions showed immunizing the birth cohort with nirsevimab …
Ask aRCie
Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities
This article describes the importance of preventing respiratory syncytial virus (RSV) in young children in France. It highlights the need for a strong partnership between …
The Efficacy and Safety of Nirsevimab for the Prevention of RSV Infection Among Infants: A Systematic Review and Meta-Analysis
This article describes a study on nirsevimab, a new drug to prevent RSV infections in infants. RSV is a virus that can cause serious lung …
The Rapidly Changing Landscape of Respiratory Syncytial Virus Prophylaxis
2023
· University of Alberta,
· McGill University
The article describes the changing ways to prevent respiratory syncytial virus (RSV) in Canada. New methods include a monoclonal antibody called nirsevimab and vaccines for …
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands
2023
· National Institute for Public Health and the Environment,
· University Medical Center Utrecht,
· Wilhelmina Children's Hospital
This article describes a study about using palivizumab to prevent RSV infections. It focuses on very preterm infants during their first year. The research took …
Game Over for RSV?
2023
· Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …